Accuray | ARAY - Gewinn Vor Steuern

Aktienkurs
0.37
Täglich Wechseln
-0.05 -11.90%
Monatlich
-27.19%
Jährlich
-79.78%
Q1 Prognose
0.48




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.36B 178M 2025-12
Accuray USD 3.23M 6.56M 2024-12
AngioDynamics USD -4M 1.74M 2025-02
Artivion USD -1.27M 1.16M 2024-09
AtriCure USD 2.36M 2.45M 2025-12
Boston Scientific USD 938M 3M 2025-09
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Inogen USD -6.06M 467K 2024-09
Mesa Laboratories USD -2.22M 6.03M 2024-12
Orthofix International USD -123.88M 97.24M 2024-12
Surmodics USD -7.51M 1.69M 2024-09
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Trinity Biotech USD -5.06M 10.74M 2025-09